Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $105,831 - $132,719
-146 Reduced 39.35%
225 $203,000
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $194,845 - $229,697
371 New
371 $216,000
Q4 2022

Feb 02, 2023

BUY
$321.55 - $374.67 $188,106 - $219,181
585 New
585 $214,000
Q2 2022

Jul 29, 2022

SELL
$278.73 - $327.27 $278,730 - $327,270
-1,000 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$224.85 - $279.04 $224,850 - $279,040
1,000 New
1,000 $276,000
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $221,600 - $272,710
-1,000 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$180.55 - $233.54 $180,550 - $233,540
1,000 New
1,000 $230,000
Q2 2020

Aug 06, 2020

SELL
$136.42 - $164.18 $17.8 Million - $21.5 Million
-130,845 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$119.05 - $147.35 $15.6 Million - $19.3 Million
130,845 New
130,845 $18.2 Million
Q4 2019

Jan 30, 2020

SELL
$106.92 - $132.43 $15 Million - $18.6 Million
-140,145 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $15 Million - $16.3 Million
140,145 New
140,145 $15.7 Million
Q2 2019

Aug 06, 2019

SELL
$110.79 - $129.32 $13.2 Million - $15.4 Million
-119,355 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$111.31 - $131.02 $13.3 Million - $15.6 Million
119,355 New
119,355 $15.5 Million
Q3 2018

Nov 09, 2018

SELL
$85.86 - $107.31 $206,922 - $258,617
-2,410 Closed
0 $0
Q2 2018

Aug 08, 2018

BUY
$75.7 - $86.88 $182,437 - $209,380
2,410 New
2,410 $206,000
Q1 2018

May 10, 2018

SELL
$74.21 - $87.6 $179,959 - $212,430
-2,425 Closed
0 $0
Q4 2017

Feb 02, 2018

SELL
$81.94 - $87.89 $2,458 - $2,636
-30 Reduced 1.22%
2,425 $205,000
Q2 2017

Aug 09, 2017

BUY
N/A
2,455
2,455 $202,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Todd Asset Management LLC Portfolio

Follow Todd Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Todd Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Todd Asset Management LLC with notifications on news.